| John Thomas Smetona, MD | |
|
9555 S 52nd Ave, Oak Lawn, IL 60453-3054 | |
| (847) 318-9330 | |
| (847) 723-9051 |
| Full Name | John Thomas Smetona |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 9555 S 52nd Ave, Oak Lawn, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497146278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 036.161424 (Illinois) | Primary |
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Researchers from Belgium led by Prof. Dirk Elewaut of the VIB-UGent Center for Inflammation Research and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to enhance the function of a specific type of immune cell that destroys tumors in multiple myeloma, a form of bone marrow cancer considered incurable.
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc., announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.
Can exposure to a single virus particle lead to infection or disease? Until now, solid proof has been lacking. Experimental research with insect larvae at Wageningen University and Simon Fraser University in Canada has shown that one virus particle is theoretically enough to cause infection and subsequent disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Thomas Smetona, MD 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | John Thomas Smetona, MD 9555 S 52nd Ave, Oak Lawn, IL 60453-3054 Ph: (847) 318-9330 |
News Archive
Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Researchers from Belgium led by Prof. Dirk Elewaut of the VIB-UGent Center for Inflammation Research and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to enhance the function of a specific type of immune cell that destroys tumors in multiple myeloma, a form of bone marrow cancer considered incurable.
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc., announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.
Can exposure to a single virus particle lead to infection or disease? Until now, solid proof has been lacking. Experimental research with insect larvae at Wageningen University and Simon Fraser University in Canada has shown that one virus particle is theoretically enough to cause infection and subsequent disease.
› Verified 6 days ago
Dr. Michael Patrick Ogilvie, MD, MBA Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St Ste 102, Oak Lawn, IL 60453 Phone: 708-684-4198 Fax: 708-684-4755 | |
Dr. Ramasamy Kalimuthu, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5346 W 95th St, Oak Lawn, IL 60453 Phone: 708-636-8222 Fax: 708-636-9798 | |
Dr. James David Schlenker, MDSC Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6311 W 95th St, Oak Lawn, IL 60453 Phone: 708-423-2258 Fax: 708-423-2305 | |
Michael Salvino, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6311 W 95th St, The Center For Reconstructive Surgery, Oak Lawn, IL 60453 Phone: 630-929-6565 Fax: 708-423-2305 | |
Niki A Christopoulos, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-8000 | |
Dr. Rajendra R Shah, M.D. Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 4944 W 95th St, Oak Lawn, IL 60453 Phone: 708-424-3999 Fax: 708-424-4017 |